I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 5 studies | 20% ± 5% | |
| B cell | 3 studies | 17% ± 2% | |
| non-classical monocyte | 3 studies | 24% ± 2% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 22% ± 5% | |
| classical monocyte | 3 studies | 22% ± 6% | |
| hematopoietic precursor cell | 3 studies | 30% ± 10% | |
| plasmablast | 3 studies | 30% ± 3% | |
| dendritic cell | 3 studies | 21% ± 4% | |
| gamma-delta T cell | 3 studies | 22% ± 8% | |
| plasmacytoid dendritic cell | 3 studies | 25% ± 6% |
